Moxidectin
Kathryn Dzintars, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Treatment of onchocerciasis due to
Onchocerca volvulus
in patients > 12 years of age
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Second-line therapy for the management of
Strongyloides stercoralis
infections
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.